Opioid Use Disorder (OUD) Market Size and Forecast 2023-2032| Cara Therapeutics Inc., AcelRx Pharmaceuticals Inc., and KemPharm Inc.

The Business Research Company’s Opioid Use Disorder (OUD) Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Opioid Use Disorder (OUD) Global Market Report 2023 evaluates opioid use disorder (oud) market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12586&type=smp

The global opioid use disorder (OUD) market is expected to grow from $3.17 billion in 2022 to $3.53 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The opioid use disorder (OUD) market is expected to reach $5.37 billion in 2027 at a CAGR of 11%.

he growing number of opioid addiction cases is expected to propel the growth of the opioid use disorder (OUD) market going forward. Opioid addiction refers to a medical condition characterized by compulsive and chronic opioid use that has harmful effects on the body. Opioids can produce a sense of euphoria and pain relief, whose continued usage can lead to the development of tolerance, where higher doses are needed to achieve the same effect, which may lead to opioid use disorder. For instance, in May 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, opioid overdose deaths in the USA increased by 15% from 70,029 in 2020 to 80,816 in 2021. Therefore, the growing number of opioid addiction cases drives the growth of the opioid use disorder (OUD) market.

Get More Information On The Opioid Use Disorder (OUD) Market Report:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

The opioid use disorder (oud) market segments in the report are:

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

The table of contents in TBRC’s opioid use disorder (oud) market report includes:

1. Executive Summary

2. Opioid Use Disorder (OUD) Market Characteristics

3. Opioid Use Disorder (OUD) Market Trends And Strategies

4. Opioid Use Disorder (OUD) Market – Macro Economic Scenario

5. Opioid Use Disorder (OUD) Market Segmentation

.

.

.

26. South America Opioid Use Disorder (OUD) Market

27. Brazil Opioid Use Disorder (OUD) Market

28. Middle East Opioid Use Disorder (OUD) Market

29. Africa Opioid Use Disorder (OUD) Market

30. Opioid Use Disorder (OUD) Market Competitive Landscape And Company Profiles

Top Major Players:

  • Pfizer Inc
  • Novartis AG
  • AstraZeneca plc
  • Viatris Inc
  • Teva Pharmaceutical Industries Ltd

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model